Strategies & Technologies Driving Drug Discovery to Market
Saving Proteomics
September 28, 2007 9:48 am | by Neil Canavan, Contributing Editor | Articles | CommentsUsers of proteomics are in need of better data solutions, prompting many companies to rescue them with improved data analysis software.
Tools a Plenty
September 28, 2007 7:59 am | by K. John Morrow, Jr., PhD Contributing Editor | Articles | CommentsKinomics is illuminating drug development with an ever-growing toolbox of screening assays.
On the Map
September 26, 2007 6:53 pm | by By Catherine Shaffer, Contributing Editor | Articles | CommentsResearchers are having more fruitful searches for cancer genes by using SNP mapping.
A New Twist
September 26, 2007 6:34 pm | by James Netterwald, PhD, MT (ASCP), Senior Editor | Articles | CommentsMicro RNAs have been implicated in cancer. What does this mean for RNAi as a cancer treatment?
One-shot Deal
September 20, 2007 6:20 pm | Articles | CommentsFunctional proteomics gets a better shot at determining protein complex equilibria by using a multiplexed surface plasmon resonance optical biosensor.
The Spice of Life
September 20, 2007 5:58 pm | by By James Netterwald, PhD, MT (ASCP), Senior Editor | Articles | CommentsScientists doing functional genomics have never had so much variety in their molecular tool box.
Revitalizing the Peptide
September 20, 2007 11:03 am | by Rodney Lappe, PhD | Articles | CommentsResearchers seeking the "next generation" of therapeutics are taking novel—but undeniably risky approaches.
Location, Location, Location
September 10, 2007 9:53 am | by George Rodrigues, PhD, Senior Scientific Manager, ARTEL | Articles | CommentsFor liquid handling quality assurance, where you calibrate impacts what you measure.
Microfluidics Helps Jazz Up Traditional Techniques
September 6, 2007 7:02 am | Articles | CommentsReal-time PCR gets faster and smaller, and decades-old gel electrophoresis faces new competition with the advent of microfluidics
How Informatics Unites Teams
September 6, 2007 7:02 am | Articles | CommentsDecentralized J&J's single portal informatics platform allows far-flung research groups to connect and collaborate
New Year, New Initiatives
September 6, 2007 7:02 am | Articles | CommentsTanuja Koppal, PhD Editor in Chief Although we continually evaluate and evolve our editorial coverage to stay in tune with the informational needs of our readers, the New Year is always a time for new beginnings. As people take time to reflect on the past year and think about what they are doing and how they can do it better, we at Drug Discovery & Development are doing the same.
Flipping a Molecular Switch
September 6, 2007 7:02 am | News | CommentsBy combining two unrelated proteins researchers created a molecular switch that they say illustrates the potential of using such switches to "rewire the cellular circuitry" and could lead to the development of novel ways to treat disease.
Biopharma’s Virtual Business Model
September 6, 2007 7:02 am | Articles | CommentsWilliam Porter Jr. At a Glance Title: Senior vice president, business development, Asia-Pacific Company: VDDI Pharmaceuticals, Brentwood, Tenn. Education: BS and MS, Michigan State University Background: Porter has more than 30 years experience in the biopharmaceutical industry, education, project management, and government relations.
Micro to Nano: Liquid Handling Gets Small
September 6, 2007 7:02 am | Articles | CommentsNanoliter and other types of liquid dispensers can speed testing, save money on compounds and reagents, and reduce error rates
Will 2005 Bring Drug Law Reform?
September 6, 2007 7:02 am | Articles | CommentsTed Agres Deputy Managing Editor, Washington Times With George W. Bush's re-election and with Republicans maintaining their hold on Congress, the pharmaceutical industry can expect free market policies to be favored should such issues as prescription price controls and drug reimportation re-emerge in 2005.
